000 | 01586 a2200421 4500 | ||
---|---|---|---|
005 | 20250514165155.0 | ||
264 | 0 | _c20040914 | |
008 | 200409s 0 0 eng d | ||
022 | _a1523-0864 | ||
024 | 7 |
_a10.1089/152308604771978291 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHansen, Jason M | |
245 | 0 | 0 |
_aA novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway. _h[electronic resource] |
260 |
_bAntioxidants & redox signaling _cFeb 2004 |
||
300 |
_a1-14 p. _bdigital |
||
500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDNA _xmetabolism |
650 | 0 | 4 |
_aFree Radicals _xmetabolism |
650 | 0 | 4 |
_aGene Expression Regulation, Developmental _xdrug effects |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 |
_aLimb Buds _xdrug effects |
650 | 0 | 4 |
_aLimb Deformities, Congenital _xchemically induced |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 |
_aOxidative Stress _xphysiology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 |
_aTeratogens _xmetabolism |
650 | 0 | 4 |
_aThalidomide _xmetabolism |
700 | 1 | _aHarris, Craig | |
773 | 0 |
_tAntioxidants & redox signaling _gvol. 6 _gno. 1 _gp. 1-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/152308604771978291 _zAvailable from publisher's website |
999 |
_c14442082 _d14442082 |